Steminent Biotherapeutics Inc. is set to present Stemchymal®, its lead investigational therapy, at the World Orphan Drug Congress (WODC) USA 2025 on April 23 in Boston and the ISCT 2025 Annual Meeting ...

Develop research skills in biotechnology and scientific knowledge applicable to ... If any of the supporting documents are not in English, you must also provide us with official or certified English ...

Steminent Biotherapeutics specializes in developing innovative stem cell-based therapeutics that offer new hope for patients ...

INmune Bio to receive US patent for next-generation mesenchymal stromal cell product, CORDStrom: Boca Raton, Florida Saturday, April 19, 2025, 17:00 Hrs [IST] INmune Bio Inc., a c ...

Discover how microbial biotechnology could reduce suffering and support global health goals, as experts call for awareness ...

Equillium, Inc. , a clinical-stage biotechnology company leveraging a deep understanding of immunobiology to develop novel therapeutics to treat severe autoimmune and inflammatory disorders, today ...

Boca Raton, Florida, US, April 16, 2025 (GLOBE NEWSWIRE) -- INmune Bio Inc. (NASDAQ: INMB), a clinical-stage biotechnology company targeting inflammation and immunology through the innate immune ...

Kiji Therapeutics engineered MSCs + IL-10 and CXCR4 offer tighter targeting and greater potency for challenging inflammatory diseases.

Reaching the milestone of 1000 enrolled patients follows Loyal’s February 2025 announcement that the FDA’s Center for ...

Two students develop edible food wrappers to reduce plastic waste and promote sustainable living, extending food shelf life.

New Chair brings more than three decades of life sciences industry experience, with a successful track record as a biotech company board ...

Myricx Bio (‘Myricx’), a UK-based biotech company focusing on the discovery and development of a completely novel class of payloads for antibody-drug conjugates (ADCs), is pleased to announce team ...